Medical devices, healthcare technology and the business of care
510(k) clearance · K253422

OAB Delivery Catheter

Cognition Medical Corp. · Decision date Oct 2, 2026

MEDTECHLEDGER EXPLANATIONK253422

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision for the OAB Delivery Catheter, submitted by Cognition Medical Corp. under 510(k) number K253422, with a decision date of October 2, 2026. The device is a Class II percutaneous catheter under 21 CFR 870.1250, carrying product codes QJP and DQY, with the database listing the regulation medical specialty as Cardiovascular and the review panel as Neurology. SESE denotes 510(k) clearance, not premarket approval.

The submission summary describes a variable stiffness, single-lumen catheter reinforced with metal braid, coil and polymer layers, a tapered tip with radiopaque markers, a hydrophilic-coated distal shaft, and ethylene oxide sterilization for single use. It lists the NG Delivery Catheter (K230609) as predicate and the Wedge Microcatheter (K172014) as reference device. The database shows a date received of 10/01/2025, which differs from the September 1, 2026 dates in the FDA letter; the reason for the discrepancy is not stated in the available text. The summary's testing section was not included in the excerpts, so performance data are unknown.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 2, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K253422
Regulatory pathway
510(k) premarket notification
Product code
QJP
Decision code
SESE
Decision date
Oct 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Percutaneous, Neurovasculature.

Product code
QJP
FDA device class
2

FDA decision timeline

  1. K253422 received

    Application receipt date recorded by FDA.

  2. K253422 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QJP

Product / regulatory recordCompanyPathwayDecision dateSource
Perfuze, Ltd.510(k) clearanceNov 5, 2026FDA
Stryker Neurovascular510(k) clearanceOct 9, 2026FDA
Alembic, LLC510(k) clearanceOct 6, 2026FDA
Route 92 Medical, Inc.510(k) clearanceSep 16, 2026FDA
Piraeus Medical, Inc.510(k) clearanceSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cognition Medical Corp.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Atlanta, GA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records